| Period End Date | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues | 33.96%0.95 | 1.44 | 0.82 | 0.53 | 0.48 |
| Cost Of Revenue | 3.43%5.07 | 5.25 | 11.64 | 4.15 | 2.86 |
24.74%9.78 | 7.84 | 6.55 | - | - | |
| Research and Development | 24.74%9.78 | 7.84 | 6.55 | - | - |
| Costs And Expenses | 12.88%32.44 | 28.74 | 32.54 | 29.74 | 143.05 |
| Operating Income/Loss | 15.35%-31.49 | -27.30 | -31.72 | -29.21 | -142.57 |
| Nonoperating Income/Loss | 40.26%-4.94 | -3.53 | -20.21 | -9.13 | -0.92 |
| Income/Loss From Equity Method Investments | 1.65%-1.49 | -1.52 | -2.31 | -1.60 | -1.92 |
| Income/Loss From Continuing Operations Before Tax | 18.20%-36.43 | -30.82 | -51.93 | -38.34 | -143.50 |
| Income Tax Expense/Benefit, Deferred | 50.51%-1.52 | -3.07 | -5.31 | -4.24 | -2.00 |
| Income Tax Expense/Benefit | 50.05%-1.52 | -3.04 | -6.26 | -3.60 | -2.22 |
25.67%-34.91 | -27.78 | -45.67 | -34.74 | -141.28 | |
| Attributable To Parent | 27.39%-26.50 | -20.81 | -37.76 | -28.33 | -84.23 |
| Available To Common Stockholders, Basic | 27.32%-26.54 | -20.84 | -37.80 | -28.36 | -84.26 |
| Attributable To Noncontrolling Interest | 20.54%-8.41 | -6.98 | -7.91 | -6.40 | - |
| Basic Average Shares | 6.79%83.12 | 77.83 | - | 55.85 | 52.55 |
| Diluted Average Shares | 6.79%83.12 | 77.83 | - | 55.85 | 52.55 |
| Basic Earnings Per Share | 18.52%-0.32 | -0.27 | - | -0.51 | -1.60 |
| Diluted Earnings Per Share | 18.52%-0.32 | -0.27 | - | -0.51 | -1.60 |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic | 7.89%0.04 | 0.04 | 0.04 | 0.03 | 0.04 |
